These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 10584376

  • 1. [Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus].
    Busque S, Demers P, Saint-Louis G, Boily JG, Tousignant J, Lemieux F, Martin G, Smeesters C, Corman J, Daloze P.
    Ann Chir; 1999; 53(8):687-9. PubMed ID: 10584376
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 3. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO.
    Transplant Proc; 2009 May; 41(6):2659-63. PubMed ID: 19715995
    [Abstract] [Full Text] [Related]

  • 4. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.
    Margreiter R, Pohanka E, Sparacino V, Sperschneider H, Kunzendorf U, Huber W, Lameire N, Andreucci VE, Donati D, Heemann U, European Switch to Tacrolimus Study Group.
    Transpl Int; 2005 Jul; 18(7):816-23. PubMed ID: 15948861
    [Abstract] [Full Text] [Related]

  • 5. Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study.
    Rostaing L, Sánchez-Fructuoso A, Franco A, Glyda M, Kuypers DR, Jaray J.
    Transpl Int; 2012 Apr; 25(4):391-400. PubMed ID: 22211928
    [Abstract] [Full Text] [Related]

  • 6. Conversion of cyclosporine A to tacrolimus following heart transplantation.
    Mathieu P, Carrier M, White M, Pellerin M, Perrault LP, Pelletier G, Pelletier LC.
    Can J Cardiol; 1999 Nov; 15(11):1229-32. PubMed ID: 10579737
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation.
    Budde K, Fritsche L, Mai I, Bauer S, Smettan S, Waiser J, Hofmann T, Hauser I, Reinke P, Neumayer HH.
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):493-7. PubMed ID: 8937932
    [Abstract] [Full Text] [Related]

  • 8. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 9. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
    Busque S, Demers P, St-Louis G, Boily JG, Tousignant J, Lemieux F, Smeesters C, Corman J, Daloze P.
    Transplant Proc; 1998 Jun; 30(4):1247-8. PubMed ID: 9636507
    [No Abstract] [Full Text] [Related]

  • 10. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [Abstract] [Full Text] [Related]

  • 11. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR, Lin CC, Lian JD.
    Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus conversion in kidney transplant recipients: analysis of 107 patients.
    Yağmurdur MC, Sevmis S, Emiroğlu R, Moray G, Bilgin N, Haberal M.
    Transplant Proc; 2004 Dec; 36(1):144-7. PubMed ID: 15013327
    [Abstract] [Full Text] [Related]

  • 13. Gingival overgrowth in a renal transplant recipient using cyclosporine A.
    Gonçalves SC, Díaz-Serrano KV, de Queiroz AM, Palioto DB, Faria G.
    J Dent Child (Chic); 2008 Dec; 75(3):313-7. PubMed ID: 19040821
    [Abstract] [Full Text] [Related]

  • 14. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW, Ketel BL, Abul-Ezz SR, Lightfoot ML.
    JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
    [Abstract] [Full Text] [Related]

  • 15. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
    Pohanka E, Margreiter R, Sparacino V, Sperschneider H, European Switch to Tacrolimus Study Group.
    Transplant Proc; 2005 May; 37(4):1874-6. PubMed ID: 15919490
    [Abstract] [Full Text] [Related]

  • 16. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
    Ramos-Cebrián M, Torregrosa JV, Gutiérrez-Dalmau A, Oppenheimer F, Campistol JM.
    Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154
    [Abstract] [Full Text] [Related]

  • 17. Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus.
    Zadrazil J, Horak P, Zahalkova J, Strebl P, Horcicka V, Krejci K, Bachleda P, Dedochova J, Valkovsky I.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):67-73. PubMed ID: 19365530
    [Abstract] [Full Text] [Related]

  • 18. Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy.
    Tang SC, Chan KW, Tang CS, Lam MF, Leung CY, Tse KC, Li CS, Ho YW, Tong MK, Lai KN, Chan TM, Hong Kong Nephrology Study Group.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3243-51. PubMed ID: 16877482
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
    Krämer BK, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Ortuño J, Sester U, Kunzendorf U, Dietl KH, Bonomini V, Rigotti P, Ronco C, Tabernero JM, Rivero M, Banas B, Mühlbacher F, Arias M, Montagnino G, European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2386-92. PubMed ID: 18258740
    [Abstract] [Full Text] [Related]

  • 20. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
    Chamienia A, Biedunkiewicz B, Król E, Debska-Slizień A, Rutkowski B.
    Transplant Proc; 2006 Jul; 38(1):81-5. PubMed ID: 16504670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.